DISC-1459 ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
254ポルフィリン症1

254. ポルフィリン症


臨床試験数 : 72 薬物数 : 53 - (DrugBank : 16) / 標的遺伝子数 : 19 - 標的パスウェイ数 : 35
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05308472
(ClinicalTrials.gov)
October 31, 202221/3/2022Study of Bitopertin to Evaluate the Safety, Tolerability, Efficacy, and PPIX Concentrations in Participants With EPP(AURORA) A Randomized, Double-blind, Placebo-Controlled Study of Bitopertin to Evaluate the Safety, Tolerability, Efficacy, and Protoporphyrin IX (PPIX) Concentrations in Participants With Erythropoietic Protoporphyria (EPP)Erythropoietic ProtoporphyriaDrug: DISC-1459;Drug: PlaceboDisc Medicine, IncNULLRecruiting18 YearsN/AAll75Phase 2United States